{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-025596","form_type":"8-K","ticker":"ZVSA","cik":"0001859007","company_name":"ZyVersa Therapeutics, Inc.","filed_at":"2023-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.845426+00:00","generated_at":"2026-06-13T02:29:09.913897+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ZyVersa prices $2.1M public offering and extends investor lockup","bullets":["Priced 'reasonable best efforts' public offering of ~12.7M shares/pre-funded warrants plus common warrants at $0.165/unit for ~$2.1M gross proceeds.","Common warrants exercisable at $0.165 for 5 years; pre-funded warrants exercisable at $0.0001 until exercised.","Amended April 2023 warrants to reduce exercise price from $1.00 to $0.165 and extend expiration to match new warrants.","Issued 3,044,152 lockup extension shares to certain investors in private placement to extend lockup to July 31, 2023.","Net proceeds intended for working capital and possible redemption of Series A preferred stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-025596","json":"https://secwatch.observer/filing/0001493152-23-025596.json","markdown":"https://secwatch.observer/filing/0001493152-23-025596.md","text":"https://secwatch.observer/filing/0001493152-23-025596.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859007/000149315223025596/0001493152-23-025596-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859007/000149315223025596/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T02:29:09.913897+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dc1432ca6bce403786cc0e73fc0ba4e48b183619","claim":"ZyVersa Therapeutics, Inc. entered into Placement Agency Agreement with A.G.P./Alliance Global Partners valued at 6.0% of the aggregate gross proceeds and reimbursement of $100,000 of expenses (effective 2023-07-24).","evidence_excerpt":"A.G.P./Alliance Global Partners (“A.G.P.”) acted as the sole placement agent for the Offering and received a fee of 6.0% of the aggregate gross proceeds and reimbursement of $100,000 of expenses, pursuant to a placement agency agreement between the Company and A.G.P. (the “Placement Agency Agreement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1859007/000149315223025596/0001493152-23-025596-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"A.G.P./Alliance Global Partners"},{"label":"Value","value":"6.0% of the aggregate gross proceeds and reimbursement of $100,000 of expenses"},{"label":"Effective","value":"2023-07-24"}],"fact_type":"material_agreement"},{"claim_id":"e5c583db8b4a01b8f266a45503606205e77487e4","claim":"ZyVersa Therapeutics, Inc. amended Warrant Amendment (effective 2023-07-24).","evidence_excerpt":"the Company amended (such amendment, the “Warrant Amendment”) certain existing warrants to purchase 1,377,996 shares of common stock that were issued in a completed best efforts offering in April 2023 (the “Best Efforts Warrants”) to reduce the existing $1.00 exercise price of the Best Efforts Warrants to the exercise price of the warrants being offered and sold in this Offering and to extend the current April 28, 2028 expiration date of the Best Efforts Warrants to the expiration date of the warrants being offered and sold in this Offering.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1859007/000149315223025596/0001493152-23-025596-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Effective","value":"2023-07-24"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}